Delivery Order 36C26122D0054-36C26124N0008
- Not listed
- Cepheid Inc. has been awarded a delivery order valued at $333,567.56 by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21), with a firm fixed-price structure and ultimate completion date of March 15, 2026. This delivery order represents a continuation of the agency's procurement of molecular diagnostic solutions from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and reagents. The award carries no set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a delivery order valued at $332,628.00 for Cepheid GeneXpert reagents and supplies. The contract, issued on April 1, 2026, operates under a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 30, 2026. This delivery order derives from Cepheid's extensive Indefinite Delivery...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a delivery order to Cepheid Inc. valued at $115,369.40 for Cepheid GeneXpert Infinity molecular reagents. The contract, awarded on October 1, 2025, has a firm fixed-price structure with an ultimate completion date of March 31, 2026. This delivery order carries no set-aside designation and represents procurement under an existing Indefinite Delivery Vehicle, enabling VISN 8 to obtain molecular diagnostic testing...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) awarded a delivery order valued at $172,455.68 to Cepheid Inc. on October 1, 2024, for Cepheid GeneXpert test systems utilizing a cost-per-test (CPT) and cost-per-reportable-result (CPRR) pricing model. The contract is structured as a firm fixed-price delivery order with no set-aside designation and will be completed by September 30, 2029. Services will be performed at Cepheid's facility in Sunnyvale,...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order with a ceiling value of $320,705.41 by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21). The award, made on October 1, 2025, with an ultimate completion date of February 4, 2026, utilizes a firm fixed-price contract structure with no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order...
- Cepheid has been awarded a delivery order valued at approximately $310K for molecular diagnostic testing system reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6), a component of the Department of Veterans Affairs' healthcare system. This firm fixed-price delivery order, with no set-aside designation, will be performed through March 31, 2026, and represents a continuation of Cepheid's ongoing supply of diagnostic solutions to the VA's regional health networks. The...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a $613,093.80 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) for Cepheid reagents. The contract was awarded on March 1, 2026, with an ultimate completion date of February 28, 2027, and carries no set-aside designation. As a leading supplier of molecular diagnostic solutions to the federal healthcare system, Cepheid will deliver diagnostic reagents and...
- Cepheid Inc. was awarded a $306,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) on October 1, 2025, for the supply of Cepheid testing kits. The contract carries an ultimate completion date of March 31, 2026, with no set-aside designation. As a molecular diagnostics manufacturer headquartered in Sunnyvale, California, Cepheid supplies the federal healthcare system with advanced diagnostic solutions, particularly its...
- This delivery order, valued at $341,103.30 and awarded on October 14, 2025, is issued under Cepheid's single-award Indefinite Delivery Contract (IDC) with Veterans Integrated Service Network (VISN) 6, which carries a total ceiling value of $32.8 million through September 30, 2030. The delivery order extends the period of performance (POP) on the existing IDC and provides molecular diagnostic testing system reagents and assays for the GeneXpert diagnostic platform to support VISN 6 medical center...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9), awarded a delivery order to Cepheid Inc. for Cepheid reagents for patient testing, valued at $34,503.84 under a firm fixed-price contract structure with no set-aside designation. The delivery order, issued on November 1, 2025, is scheduled for ultimate completion by September 30, 2026, and represents a de-obligation of excess fiscal year 2026 funds on an existing delivery order vehicle. Cepheid, headquartered...
- 36C26122D0054Indefinite Delivery Contract
- 36C26122D0054-36C26124N0008Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 21, awarded Cepheid Inc. a delivery order modification totaling $887,899.53 for Cepheid GeneXpress and GeneXpert reagents under a firm fixed-price contract with no set-aside designation. The award, effective January 20, 2024, represents a modification to increase funding under existing delivery orders (0003AM) and add a new delivery order (0003AN), with an ultimate completion date of January 19, 2025. The work will be performed in Palo Alto, California, and continues Cepheid's established role as a primary federal supplier of molecular diagnostic testing solutions to the VA healthcare system. This delivery order supports VISN 21's clinical laboratory operations and infectious disease testing requirements by supplying reagents and test kits for Cepheid's GeneXpert diagnostic platform, which performs rapid molecular detection of infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other pathogens. Cepheid maintains extensive prime Indefinite Delivery Contracts with multiple VA networks, including a $32.8 million contract with VISN 6 extending through September 2030, demonstrating the VA's sustained reliance on the company's diagnostic capabilities. The firm fixed-price structure reflects competitive market positioning in federal molecular diagnostics procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($277k) | 3/23/26 | |
| P00001 | Supplemental Agreement for work within scope | $246.6k | 1/29/24 | |
| Not listed | Not listed | $918.8k | 10/3/23 |